LEVETIRACETAM

Product NDC
51991-651
Requested package NDC
51991-651-16
11-digit product format
519910651
Labeler code
51991
Product ID
51991-651_9e6c00bc-2eaf-4cd8-be6b-3a5506acfa6b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
LEVETIRACETAM
Dosage form
SOLUTION
Route
ORAL
Labeler
Breckenridge Pharmaceutical, Inc.
Application
ANDA079120
Marketing category
ANDA
Marketing start
2013-11-19
Marketing end
2024-12-31
Substance
LEVETIRACETAM
Active strength
100 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage51991-65151991-651-16DDiscontinued by firm2026-07-31

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A079120-001LEVETIRACETAMLEVETIRACETAM100MG/MLSOLUTION / ORALAA2009-01-16

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A079120-001AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06A079120-001LEVETIRACETAM100MG/MLSOLUTION / ORALAA2009-01-16a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-01 22:54:322026-06A079120-001AA1a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LEVETIRACETAMLEVETIRACETAMBionpharma Inc.1d75b15e-881c-a00f-e063-6394a90a41382026-04-17Warnings, Adverse reactionsExact identifier
application applno (ANDA): 079120
application number: ANDA079120
LEVETIRACETAMLEVETIRACETAMKesin Pharma Corporation30a4626d-74f3-6385-e063-6394a90a29502025-03-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 079120
application number: ANDA079120

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
51991-651-16ML - Milliliter51991-65116ae2b44-f2a4-435b-999a-0188830fa35e12012-07-24

DailyMed Socrata Ingredients#

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
51991-651-1651991065116473 mL in 1 BOTTLE (51991-651-16) 473 ml2013-11-192024-12-31NoNoCurrent